About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Depression Clinical Trials | 3,199 Studies Recruiting

Clinical TrialsDepression

Depression Clinical Trials

Browse 3,199 clinical trials for depression. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 181-200 of 3,199 trials

CompletedTreatment of Patients With Major Depressive Disorder With MK0869 (0869-063)A clinical study to determine the efficacy and safety of MK0869 in the treatment of depression.NCT00034944 CompletedBehavioral and Electrophysiological Effects of Ketamine in Treatment-Resistant DepressionThe overarching goal of the present study is to evaluate the effect of a subanesthetic dose of ketamine 24-hour post-injection on resting state functional connectivity, cognitive…NCT04239963·Belmont, Massachusetts Not yet recruitingPersonalized Accelerated iTBS Versus Sham for Major Depressive DisorderThis randomized, double-blind, sham-controlled, parallel-group clinical trial will evaluate the efficacy and safety of individualized functional connectivity-guided accelerated…NCT07843875 RecruitingAccelerated Neuromodulation of Anterior Cingulate Cortex for DepressionThe goal of this clinical trial is to test whether an accelerated deep Transcranial Magnetic Stimulation (dTMS) protocol can reduce depressive symptoms in older adults (ages…NCT07212465·Toronto, Ontario

Related Searches

major depressivetrials mddtrials

Data from ClinicalTrials.govTerms

UnknownKetamine for Major Depressive DisorderThe purpose of this study is to measure the amount of ketamine in blood over time in subjects diagnosed with Major Depressive Disorder (MDD) and explore the anti-depressive…NCT03721900·Gaithersburg, Maryland and 2 others

CompletedA Study of Intermittent Doses of CERC-301 in MDDThere is a significant unmet medical need for rapidly acting treatment of subjects with severe major depressive disorder (MDD) who have not adequately responded to antidepressant…NCT02459236·Newport Beach, California and 12 others

RecruitingNBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)The study will evaluate the efficacy of NBI-1065845 compared with placebo as an adjunctive treatment in participants with MDD on improving symptoms of depression.NCT06963021·Chino, California and 34 others

RecruitingLeucine in Midlife DepressionThe study aims to investigate the effects of a 6-week leucine challenge on brain chemistry, connectivity, and behavior in people with midlife depression.NCT06580145·Atlanta, Georgia

CompletedUniversal vs. Targeted School Screening for Adolescent Major Depressive DisorderThe primary goal of the proposed study is to compare the effectiveness of universal school based screening for adolescent major depressive disorder to the current school process…NCT03716869·Hershey, Pennsylvania

UnknownMovement for Depression - An RCT Assessing the Effects of Physical Activity Promotion for People With MDDRandomized clinical trial that aims to increase physical activity levels in people with depression and to evaluate if the increase on PA levels has impact on clinical and…NCT03403881·Porto Alegre, Rio Grande do Sul

CompletedEfficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive DisordersThe purpose of this study is to demonstrate superior efficacy of Quetiapine fumarate sustained release (SEROQUEL) compared with placebo when used as a mono-therapy in the…NCT00326144·Phoenix, Arizona and 33 others

CompletedChildhood Adversity, Genetic Polymorphisms and Stress in First Onset Major DepressionThe Blue Sky Project, a 5-year study funded by the Canadian Institutes of Health Research, seeks to examine how genetics and early life experiences work together to cause a…NCT00517764·Kingston, Ontario and 1 other

CompletedStudy Evaluating DVS-233 for Treatment of Outpatients With Major Depressive DisorderTo evaluate the long-term safety of desvenlafaxine sustained release (DVS-233SR) during open-label treatment of outpatients with major depressive disorder (MDD).NCT00452595

CompletedLipopolysaccharide (LPS) Challenge in DepressionLPS Challenge in Individuals with Major Depressive DisorderNCT03142919·Tulsa, Oklahoma

UnknownDisorder-tailored Transcranial Direct Current Stimulation (tDCS) of the Prefrontal CortexMajor depressive disorder (MDD) is a common, recurrent, and frequent chronic disorder.NCT02715128·Munich

RecruitingNo Time to Wait: Single Session InterventionMental health problems in youth are prevalent, but early intervention effectively reduces symptoms, substance abuse risk, suicide, and comorbidities.NCT07383467·Hong Kong

CompletedEvaluation of Efficacy and Safety of add-on Sarcosine in Patients With Major Depressive DisorderOne-third of the patients with major depressive disorder do not respond to conventional antidepressants that act through the mono-aminergic system.NCT04975100·Bhubaneswar, Odisha

RecruitingFlumazenil for Benzodiazepine Reversal in Electroconvulsive TherapyThe goal of this study is to investigate whether administering flumazenil to reverse the effects of benzodiazepines and/or zopiclone during electroconvulsive therapy (ECT) can…NCT07619092·Frederiksberg, Capital Region

CompletedLong Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)A clinical study to determine the efficacy and safety of an investigational medication (MK0869) in the treatment of depression.NCT00048594

CompletedFeasibility Pilot of Accelerated Stimulation With TMS for Treatment of Major Depressive Disorder (FAST-MDD)This is a mixed-methods study that includes three steps.NCT06961851·Minneapolis, Minnesota

PreviousPage 10 of 160Next